Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OCUL
Stock Latest News
Company Announcements
Ocular Therapeutix Approves Key Amendments at Annual Meeting
2M ago
8K
OCUL
Premium
Ratings
Ocular Therapeutix’s Promising Clinical Trials and Strategic Advancements Justify Buy Rating
2M ago
OCUL
Premium
Ratings
Strong Buy Rating for Ocular Therapeutix Driven by Promising Axpaxli Program and Market Potential
2M ago
OCUL
Premium
Ratings
Ocular Therapeutix’s Promising Developments and Strategic Execution Justify Buy Rating
2M ago
OCUL
Premium
The Fly
Ocular Therapeutix to close enrollment this week for SOL-R
2M ago
OCUL
Premium
Ratings
Ocular Therapeutix: Promising Pipeline and Strategic Developments Justify Buy Rating Despite Current Financial Challenges
3M ago
OCUL
Premium
Company Announcements
Ocular Therapeutix Advances in Retinal Treatment Trials
3M ago
OCUL
Premium
Ratings
Strategic Advancements and Financial Updates Drive Buy Rating for Ocular Therapeutix
3M ago
OCUL
Premium
Ratings
Optimistic Buy Rating for Ocular Therapeutix Driven by Streamlined Trials and Promising FDA Engagement
3M ago
OCUL
Premium
The Fly
Morning Movers: Skechers surges following take-private deal
3M ago
HHH
SKX
Premium
The Fly
Ocular Therapeutix reports Q1 EPS (38c), consensus (28c)
3M ago
OCUL
Premium
The Fly
Ocular Therapeutix sees cash runway into 2028
3M ago
OCUL
Premium
Pre-Earnings
Ocular Therapeutix Inc (OCUL) Q1 Earnings Cheat Sheet
3M ago
OCUL
Premium
The Fly
Ocular Therapeutix initiated with an Outperform at William Blair
4M ago
OCUL
Premium
The Fly
Ocular Therapeutix initiated with an Outperform at William Blair
4M ago
OCUL
Premium
Ratings
Buy Recommendation for Ocular Therapeutix: Axpaxli’s Potential to Revolutionize nAMD Treatment
4M ago
OCUL
Premium
The Fly
Ocular Therapeutix added to Analyst Current Favorites list at Raymond James
4M ago
OCUL
Premium
The Fly
Ocular Therapeutix initiated with an Outperform at RBC Capital
5M ago
OCUL
Premium
Weekend Updates
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
5M ago
U
BEAM
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ALDX
DWTX
Premium
Ratings
Strategic Trial Adjustments and Efficiency Boost Ocular Therapeutix’s Prospects: A Buy Rating Justification
5M ago
OCUL
Premium
The Fly
Ocular Therapeutix initiated with a Buy at Needham
5M ago
OCUL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
